Moderna was recently told that the Health and Human Services Department (HHS) had withdrawn a $766million grant awarded by ...

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine, causing criticism from experts.

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.

Moderna said mNEXSPIKE was approved by the FDA for use in adults aged 65 and up, as well as some individuals aged 12 to 64.

If you've ever had chickenpox in your childhood, chances are you're likely to develop shingles in the future. While people might assume that shingles — a painful, blistering rash — only ...

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

The FDA approved Moderna’s new Covid-19 vaccine late Friday, though it placed restrictions on its use that the company’s ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...